Immunohistochemical Markers for Prospective Studies in Neurofibromatosis-1 Porcine Models

David K. Meyerholz, Georgina K. Ofori-Amanfo, Mariah R. Leidinger, J. Adam Goeken, Rajesh Khanna, Jessica C. Sieren, Benjamin W. Darbro, Dawn E. Quelle, Jill M. Weimer

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Neurofibromatosis type 1 (NF1) is a common, cancer-predisposing disease caused by mutations in the NF1 tumor gene. Patients with NF1 have an increased risk for benign and malignant tumors of the nervous system (e.g., neurofibromas, malignant peripheral nerve sheath tumors, gliomas) and other tissues (e.g., leukemias, rhabdomyosarcoma, etc.) as well as increased susceptibility to learning disabilities, chronic pain/migraines, hypertension, pigmentary changes, and developmental lesions (e.g., tibial pseudoarthrosis). Pigs are an attractive and upcoming animal model for future NF1 studies, but a potential limitation to porcine model research has been the lack of validated reagents for direct translational study to humans. To address that issue, we used formalin-fixed tissues (human and pigs) to evaluate select immunohistochemical markers (activated caspase-3, allograft inflammatory factor-1, beta-tubulin III, calbindin D, CD13, CD20, desmin, epithelial membrane antigen, glial fibrillary acidic protein, glucose transporter-1, laminin, myelin basic protein, myoglobin, proliferating cell nuclear antigen, S100, vimentin, and von Willebrand factor). The markers were validated by comparing known expression and localization in human and pig tissues. Validation of these markers on fixed tissues will facilitate prospective immunohistochemical studies of NF1 pigs, as well as other pig models, in a more efficient, reproducible, and translationally relevant manner.

Original languageEnglish (US)
Pages (from-to)607-618
Number of pages12
JournalJournal of Histochemistry and Cytochemistry
Volume65
Issue number10
DOIs
StatePublished - Oct 1 2017

Fingerprint

Neurofibromatosis 1
Swine
Prospective Studies
Neurofibromatosis 1 Genes
Nervous System Neoplasms
Calbindins
Neurofibroma
Mucin-1
Pseudarthrosis
Desmin
Myelin Basic Protein
Facilitative Glucose Transport Proteins
Rhabdomyosarcoma
Myoglobin
Learning Disorders
Glial Fibrillary Acidic Protein
Neurilemmoma
Proliferating Cell Nuclear Antigen
von Willebrand Factor
Vimentin

Keywords

  • antibody
  • formalin fixation
  • humans
  • immunohistochemistry
  • markers
  • neurofibromatosis type 1
  • pigs
  • tissues

ASJC Scopus subject areas

  • Anatomy
  • Histology

Cite this

Meyerholz, D. K., Ofori-Amanfo, G. K., Leidinger, M. R., Goeken, J. A., Khanna, R., Sieren, J. C., ... Weimer, J. M. (2017). Immunohistochemical Markers for Prospective Studies in Neurofibromatosis-1 Porcine Models. Journal of Histochemistry and Cytochemistry, 65(10), 607-618. https://doi.org/10.1369/0022155417729357

Immunohistochemical Markers for Prospective Studies in Neurofibromatosis-1 Porcine Models. / Meyerholz, David K.; Ofori-Amanfo, Georgina K.; Leidinger, Mariah R.; Goeken, J. Adam; Khanna, Rajesh; Sieren, Jessica C.; Darbro, Benjamin W.; Quelle, Dawn E.; Weimer, Jill M.

In: Journal of Histochemistry and Cytochemistry, Vol. 65, No. 10, 01.10.2017, p. 607-618.

Research output: Contribution to journalArticle

Meyerholz, DK, Ofori-Amanfo, GK, Leidinger, MR, Goeken, JA, Khanna, R, Sieren, JC, Darbro, BW, Quelle, DE & Weimer, JM 2017, 'Immunohistochemical Markers for Prospective Studies in Neurofibromatosis-1 Porcine Models', Journal of Histochemistry and Cytochemistry, vol. 65, no. 10, pp. 607-618. https://doi.org/10.1369/0022155417729357
Meyerholz, David K. ; Ofori-Amanfo, Georgina K. ; Leidinger, Mariah R. ; Goeken, J. Adam ; Khanna, Rajesh ; Sieren, Jessica C. ; Darbro, Benjamin W. ; Quelle, Dawn E. ; Weimer, Jill M. / Immunohistochemical Markers for Prospective Studies in Neurofibromatosis-1 Porcine Models. In: Journal of Histochemistry and Cytochemistry. 2017 ; Vol. 65, No. 10. pp. 607-618.
@article{d7971de738834dea875f35836fd8bdcd,
title = "Immunohistochemical Markers for Prospective Studies in Neurofibromatosis-1 Porcine Models",
abstract = "Neurofibromatosis type 1 (NF1) is a common, cancer-predisposing disease caused by mutations in the NF1 tumor gene. Patients with NF1 have an increased risk for benign and malignant tumors of the nervous system (e.g., neurofibromas, malignant peripheral nerve sheath tumors, gliomas) and other tissues (e.g., leukemias, rhabdomyosarcoma, etc.) as well as increased susceptibility to learning disabilities, chronic pain/migraines, hypertension, pigmentary changes, and developmental lesions (e.g., tibial pseudoarthrosis). Pigs are an attractive and upcoming animal model for future NF1 studies, but a potential limitation to porcine model research has been the lack of validated reagents for direct translational study to humans. To address that issue, we used formalin-fixed tissues (human and pigs) to evaluate select immunohistochemical markers (activated caspase-3, allograft inflammatory factor-1, beta-tubulin III, calbindin D, CD13, CD20, desmin, epithelial membrane antigen, glial fibrillary acidic protein, glucose transporter-1, laminin, myelin basic protein, myoglobin, proliferating cell nuclear antigen, S100, vimentin, and von Willebrand factor). The markers were validated by comparing known expression and localization in human and pig tissues. Validation of these markers on fixed tissues will facilitate prospective immunohistochemical studies of NF1 pigs, as well as other pig models, in a more efficient, reproducible, and translationally relevant manner.",
keywords = "antibody, formalin fixation, humans, immunohistochemistry, markers, neurofibromatosis type 1, pigs, tissues",
author = "Meyerholz, {David K.} and Ofori-Amanfo, {Georgina K.} and Leidinger, {Mariah R.} and Goeken, {J. Adam} and Rajesh Khanna and Sieren, {Jessica C.} and Darbro, {Benjamin W.} and Quelle, {Dawn E.} and Weimer, {Jill M.}",
year = "2017",
month = "10",
day = "1",
doi = "10.1369/0022155417729357",
language = "English (US)",
volume = "65",
pages = "607--618",
journal = "Journal of Histochemistry and Cytochemistry",
issn = "0022-1554",
publisher = "Histochemical Society Inc.",
number = "10",

}

TY - JOUR

T1 - Immunohistochemical Markers for Prospective Studies in Neurofibromatosis-1 Porcine Models

AU - Meyerholz, David K.

AU - Ofori-Amanfo, Georgina K.

AU - Leidinger, Mariah R.

AU - Goeken, J. Adam

AU - Khanna, Rajesh

AU - Sieren, Jessica C.

AU - Darbro, Benjamin W.

AU - Quelle, Dawn E.

AU - Weimer, Jill M.

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Neurofibromatosis type 1 (NF1) is a common, cancer-predisposing disease caused by mutations in the NF1 tumor gene. Patients with NF1 have an increased risk for benign and malignant tumors of the nervous system (e.g., neurofibromas, malignant peripheral nerve sheath tumors, gliomas) and other tissues (e.g., leukemias, rhabdomyosarcoma, etc.) as well as increased susceptibility to learning disabilities, chronic pain/migraines, hypertension, pigmentary changes, and developmental lesions (e.g., tibial pseudoarthrosis). Pigs are an attractive and upcoming animal model for future NF1 studies, but a potential limitation to porcine model research has been the lack of validated reagents for direct translational study to humans. To address that issue, we used formalin-fixed tissues (human and pigs) to evaluate select immunohistochemical markers (activated caspase-3, allograft inflammatory factor-1, beta-tubulin III, calbindin D, CD13, CD20, desmin, epithelial membrane antigen, glial fibrillary acidic protein, glucose transporter-1, laminin, myelin basic protein, myoglobin, proliferating cell nuclear antigen, S100, vimentin, and von Willebrand factor). The markers were validated by comparing known expression and localization in human and pig tissues. Validation of these markers on fixed tissues will facilitate prospective immunohistochemical studies of NF1 pigs, as well as other pig models, in a more efficient, reproducible, and translationally relevant manner.

AB - Neurofibromatosis type 1 (NF1) is a common, cancer-predisposing disease caused by mutations in the NF1 tumor gene. Patients with NF1 have an increased risk for benign and malignant tumors of the nervous system (e.g., neurofibromas, malignant peripheral nerve sheath tumors, gliomas) and other tissues (e.g., leukemias, rhabdomyosarcoma, etc.) as well as increased susceptibility to learning disabilities, chronic pain/migraines, hypertension, pigmentary changes, and developmental lesions (e.g., tibial pseudoarthrosis). Pigs are an attractive and upcoming animal model for future NF1 studies, but a potential limitation to porcine model research has been the lack of validated reagents for direct translational study to humans. To address that issue, we used formalin-fixed tissues (human and pigs) to evaluate select immunohistochemical markers (activated caspase-3, allograft inflammatory factor-1, beta-tubulin III, calbindin D, CD13, CD20, desmin, epithelial membrane antigen, glial fibrillary acidic protein, glucose transporter-1, laminin, myelin basic protein, myoglobin, proliferating cell nuclear antigen, S100, vimentin, and von Willebrand factor). The markers were validated by comparing known expression and localization in human and pig tissues. Validation of these markers on fixed tissues will facilitate prospective immunohistochemical studies of NF1 pigs, as well as other pig models, in a more efficient, reproducible, and translationally relevant manner.

KW - antibody

KW - formalin fixation

KW - humans

KW - immunohistochemistry

KW - markers

KW - neurofibromatosis type 1

KW - pigs

KW - tissues

UR - http://www.scopus.com/inward/record.url?scp=85030175438&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030175438&partnerID=8YFLogxK

U2 - 10.1369/0022155417729357

DO - 10.1369/0022155417729357

M3 - Article

C2 - 28846462

AN - SCOPUS:85030175438

VL - 65

SP - 607

EP - 618

JO - Journal of Histochemistry and Cytochemistry

JF - Journal of Histochemistry and Cytochemistry

SN - 0022-1554

IS - 10

ER -